General Home Investors News

France : EIB and MedinCell sign a new €40 million loan agreement to support development of innovative treatments

By MedincellNovember 23, 2022March 15th, 2024No Comments

France : EIB and MedinCell sign a new €40 million loan agreement to support development of innovative treatments

November 23, 2022

Previous PostDetails of the financing agreement signed by MedinCell and the European Investment Bank (EIB)
Next PostMedinCell announces its participation in the Jefferies London Healthcare Conference 2022, 15-17 November in London

Better medicine for all

Website by ScreenUp